ArticleiScience2026

SFMBT2 hypermethylation promotes colorectal cancer progression and is a potential noninvasive biomarker for advanced CRC.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.